Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Neurosurgery

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 302 articles:
HTML format



Single Articles


    July 2021
  1. SOYFER V, Gutfeld O, Shamai S, Schlocker A, et al
    COVID-19 Vaccine-Induced Radiation Recall Phenomenon.
    Int J Radiat Oncol Biol Phys. 2021;110:957-961.
    PubMed     Abstract available


    April 2021
  2. MENDEZ ROMERO A, Schillemans W, van Os R, Koppe F, et al
    The Dutch-Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:1377-1386.
    PubMed     Abstract available


  3. FOLKERT MR, Meyer JJ, Aguilera TA, Yokoo T, et al
    Long-Term Results of a Phase 1 Dose-Escalation Trial and Subsequent Institutional Experience of Single-Fraction Stereotactic Ablative Radiation Therapy for Liver Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:1387-1395.
    PubMed     Abstract available


  4. QU XM, Chen Y, Zaric GS, Senan S, et al
    Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of the SABR-COMET Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2021;109:1176-1184.
    PubMed     Abstract available


  5. MERCIER C, Claessens M, Buys MSc A, Gryshkevych S, et al
    Stereotactic Ablative Radiation Therapy to All Lesions in Patients With Oligometastatic Cancers: A Phase 1 Dose-Escalation Trial.
    Int J Radiat Oncol Biol Phys. 2021;109:1195-1205.
    PubMed     Abstract available


  6. VAN LIMBERGEN EJ, Hoeben A, Lieverse RIY, Houben R, et al
    Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 Study.
    Int J Radiat Oncol Biol Phys. 2021;109:1421-1430.
    PubMed     Abstract available


  7. TINKLE CL, Singh C, Lloyd S, Guo Y, et al
    Stereotactic Body Radiation Therapy for Metastatic and Recurrent Solid Tumors in Children and Young Adults.
    Int J Radiat Oncol Biol Phys. 2021;109:1396-1405.
    PubMed     Abstract available


  8. ZHANG J, Wang L, Li X, Huang M, et al
    Quantification of Intrafraction and Interfraction Tumor Motion Amplitude and Prediction Error for Different Liver Tumor Trajectories in Cyberknife Synchrony Tracking.
    Int J Radiat Oncol Biol Phys. 2021;109:1588-1605.
    PubMed     Abstract available


  9. KUMAR A, Straka C, Courtney PT, Vitzthum L, et al
    Cost-Effectiveness Analysis of Stereotactic Ablative Radiation Therapy in Patients With Oligometastatic Cancer.
    Int J Radiat Oncol Biol Phys. 2021;109:1185-1194.
    PubMed     Abstract available


    March 2021
  10. SANTOS PMG, Lapen K, Zhang Z, Lobaugh S, et al
    Trends in Radiation Therapy for Bone Metastases, 2015 to 2017: Choosing Wisely in the Era of Complex Radiation.
    Int J Radiat Oncol Biol Phys. 2021;109:923-931.
    PubMed     Abstract available


  11. ZHANG J, Wang C, Sheng Y, Palta M, et al
    An Interpretable Planning Bot for Pancreas Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;109:1076-1085.
    PubMed     Abstract available


  12. LYDIARD PGDIP S, Blanck O, Hugo G, O'Brien R, et al
    A Review of Cardiac Radioablation (CR) for Arrhythmias: Procedures, Technology, and Future Opportunities.
    Int J Radiat Oncol Biol Phys. 2021;109:783-800.
    PubMed     Abstract available


  13. SHAHI J, Poon I, Ung YC, Tsao M, et al
    Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:764-774.
    PubMed     Abstract available


  14. SOGONO P, Bressel M, David S, Shaw M, et al
    Safety, Efficacy, and Patterns of Failure After Single-Fraction Stereotactic Body Radiation Therapy (SBRT) for Oligometastases.
    Int J Radiat Oncol Biol Phys. 2021;109:756-763.
    PubMed     Abstract available


    February 2021
  15. DUNNE EM, Liu M
    Postoperative Stereotactic Body Radiation Therapy, Then Observe.
    Int J Radiat Oncol Biol Phys. 2021;109:316.
    PubMed    


  16. DE BARI B
    Cautious SBRT.
    Int J Radiat Oncol Biol Phys. 2021;109:315.
    PubMed    


  17. KIM N, Cheng J, Huang WY, Kimura T, et al
    Dose-Response Relationship in Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: A Pooled Analysis of an Asian Liver Radiation Therapy Group Study.
    Int J Radiat Oncol Biol Phys. 2021;109:464-473.
    PubMed     Abstract available


  18. LO CH, Lee HL, Hsiang CW, Chiou JF, et al
    Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival and Liver Toxicity in Patients With Hepatocellular Carcinoma Treated With Stereotactic Ablative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;109:474-484.
    PubMed     Abstract available


    January 2021
  19. SALAMA JK, Giuliani ME, Robinson CG, Daly ME, et al
    Single-fraction SBRT for Early Stage NSCLC-A Viable Option in "These Uncertain Times"?
    Int J Radiat Oncol Biol Phys. 2021;109:1-4.
    PubMed    


  20. JACKSON WC, Tang M, Maurino C, Mendiratta-Lala M, et al
    Individualized Adaptive Radiation Therapy Allows for Safe Treatment of Hepatocellular Carcinoma in Patients With Child-Turcotte-Pugh B Liver Disease.
    Int J Radiat Oncol Biol Phys. 2021;109:212-219.
    PubMed     Abstract available


    December 2020
  21. MCDONALD BA, Vedam S, Yang J, Wang J, et al
    Initial Feasibility and Clinical Implementation of Daily MR-guided Adaptive Head and Neck Cancer Radiotherapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation.
    Int J Radiat Oncol Biol Phys. 2020 Dec 16. pii: S0360-3016(20)34661.
    PubMed     Abstract available


  22. JIAO Z, Li H, Xiao Y, Aggarwal C, et al
    Integration of risk survival measures estimated from pre- and post-treatment CT scans improves stratification of early stage non-small cell lung cancer patients treated with stereotactic body radiation therapy.
    Int J Radiat Oncol Biol Phys. 2020 Dec 14. pii: S0360-3016(20)34660.
    PubMed     Abstract available


  23. TANG C, Lei X, Smith GL, Pan HY, et al
    Influence of Geography on Prostate Cancer Treatment.
    Int J Radiat Oncol Biol Phys. 2020 Dec 11. pii: S0360-3016(20)34595.
    PubMed     Abstract available


  24. KIMURA T, Takeda A, Tsurugai Y, Kawano R, et al
    A Multi-Institutional Retrospective Study of Repeated Stereotactic Body Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2020;108:1265-1275.
    PubMed     Abstract available


  25. SEBASTIAN NT, Miller ED, Yang X, Diaz DA, et al
    A Pilot Trial Evaluating Stereotactic Body Radiation Therapy to Induce Hyperemia in Combination With Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2020;108:1276-1283.
    PubMed     Abstract available


  26. DEE EC, Muralidhar V, Arega MA, Kishan AU, et al
    Factors influencing non-completion of radiotherapy among men with localized prostate cancer.
    Int J Radiat Oncol Biol Phys. 2020 Dec 1. pii: S0360-3016(20)34604.
    PubMed     Abstract available


    November 2020
  27. SPENCER KL, Tree AC
    Commentary on Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020;108:927-929.
    PubMed    


  28. BURRI SH, Ward MC, Prabhu RS
    Hobgoblins, Iron Lungs, and Surgical Perturbation Failure?
    Int J Radiat Oncol Biol Phys. 2020;108:996-998.
    PubMed    


  29. VASQUEZ OSORIO EM, McCallum H, Bedair A, Faivre-Finn C, et al
    Protecting the Heart: A Practical Approach to Account for the Full Extent of Heart Motion in Radiation Therapy Planning.
    Int J Radiat Oncol Biol Phys. 2020;108:1082-1090.
    PubMed     Abstract available


  30. PARIKH NR, Kundu P, Levin-Epstein R, Chang EM, et al
    Time-Driven Activity-Based Costing Comparison of Stereotactic Radiosurgery to Multiple Brain Lesions Using Single-Isocenter Versus Multiple-Isocenter Technique.
    Int J Radiat Oncol Biol Phys. 2020;108:999-1007.
    PubMed     Abstract available


  31. SIVA S, Correa RJM, Warner A, Staehler M, et al
    Stereotactic Ablative Radiotherapy for >/=T1b Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK).
    Int J Radiat Oncol Biol Phys. 2020;108:941-949.
    PubMed     Abstract available


  32. GOGINENI E, Rana Z, Soberman D, Sidiqi B, et al
    Biochemical control and toxicity outcomes of SBRT vs LDR brachytherapy in the treatment of low and intermediate risk prostate cancer.
    Int J Radiat Oncol Biol Phys. 2020 Nov 7. pii: S0360-3016(20)34489.
    PubMed     Abstract available


  33. JOHNSTONE C, Recht A
    It's Time...
    Int J Radiat Oncol Biol Phys. 2020;108:572-574.
    PubMed    


  34. YU JB, Brock KK, Campbell AM, Chen AB, et al
    Proceedings of the ASTRO-RSNA Oligometastatic Disease Research Workshop.
    Int J Radiat Oncol Biol Phys. 2020;108:539-545.
    PubMed     Abstract available


  35. BYUN HK, Yoon HI, Cho J, Shim KW, et al
    Optimization of Intracranial Germinoma Treatment: Radiotherapy Alone with Reduced Volume and Dose.
    Int J Radiat Oncol Biol Phys. 2020;108:657-666.
    PubMed     Abstract available


    October 2020
  36. LING DC, Vargo JA, Beriwal S
    Breast, Prostate, and Rectal Cancer: Should 5-5-5 Be a New Standard of Care?
    Int J Radiat Oncol Biol Phys. 2020;108:390-393.
    PubMed    


    September 2020
  37. SANDERS JW, Venkatesan AM, Levitt CA, Bathala T, et al
    Fully balanced SSFP without an endorectal coil for post-implant QA of MRI-assisted radiosurgery (MARS) of prostate cancer: a prospective study.
    Int J Radiat Oncol Biol Phys. 2020 Sep 24. pii: S0360-3016(20)34342.
    PubMed     Abstract available


  38. KORPICS MC, Polley MY, Bhave SR, Redler G, et al
    A Validated T Cell Radiomics Score Is Associated With Clinical Outcomes Following Multisite SBRT and Pembrolizumab.
    Int J Radiat Oncol Biol Phys. 2020;108:189-195.
    PubMed     Abstract available


  39. RATNAYAKE G, Reinwald S, Shackleton M, Moore M, et al
    Stereotactic Radiation Therapy Combined With Immunotherapy Against Metastatic Melanoma: Long-Term Results of a Phase 1 Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2020;108:150-156.
    PubMed     Abstract available


  40. TIAN S, Switchenko JM, Buchwald ZS, Patel PR, et al
    Lung Stereotactic Body Radiation Therapy and Concurrent Immunotherapy: A Multicenter Safety and Toxicity Analysis.
    Int J Radiat Oncol Biol Phys. 2020;108:304-313.
    PubMed     Abstract available


    July 2020
  41. BERGAMIN S, Eade T, Kneebone A, Booth J, et al
    Interim results of a prospective PSMA-directed focal stereotactic re-irradiation trial for locally recurrent prostate cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jul 10. pii: S0360-3016(20)31412.
    PubMed     Abstract available


  42. SANDERS JW, Lewis GD, Thames HD, Kudchadker RJ, et al
    Machine segmentation of pelvic anatomy in MRI-assisted radiosurgery (MARS) for prostate cancer brachytherapy.
    Int J Radiat Oncol Biol Phys. 2020 Jul 4. pii: S0360-3016(20)31396.
    PubMed     Abstract available


  43. TSANG RW, Laperriere N
    Whole Brain Radiation Is Still the Standard in the Salvage Situation.
    Int J Radiat Oncol Biol Phys. 2020;107:403.
    PubMed    


  44. BERTHO A, Dos Santos M, Buard V, Paget V, et al
    Preclinical Model of Stereotactic Ablative Lung Irradiation Using Arc Delivery in the Mouse: Effect of Beam Size Changes and Dose Effect at Constant Collimation.
    Int J Radiat Oncol Biol Phys. 2020;107:548-562.
    PubMed     Abstract available


    June 2020
  45. HELIS CA, Hughes RT, Glenn CW, Lanier CM, et al
    Predictors of Adverse Radiation Effect in Brain Metastasis Patients Treated with Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy.
    Int J Radiat Oncol Biol Phys. 2020 Jun 29. pii: S0360-3016(20)31344.
    PubMed     Abstract available


  46. PARIKH NR, Kishan AU, Kane N, Diaz-Perez S, et al
    Phase I Trial of Stereotactic Body Radiotherapy Neoadjuvant to Radical Prostatectomy for Patients with High-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jun 17. pii: S0360-3016(20)31251.
    PubMed     Abstract available


  47. PARIKH NR, Chang EM, Nickols NG, Rettig MB, et al
    Cost-effectiveness of metastasis-directed therapy in oligorecurrent hormone-sensitive prostate cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jun 13. pii: S0360-3016(20)31250.
    PubMed     Abstract available


  48. JACCARD M, Zilli T, Dubouloz A, Escude L, et al
    Urethra-sparing stereotactic body radiotherapy for prostate cancer: quality assuranceof a randomized phase II trial.
    Int J Radiat Oncol Biol Phys. 2020 Jun 11. pii: S0360-3016(20)31242.
    PubMed     Abstract available


  49. CHANG DT, Pollom EL, Keane FK, Wo JY, et al
    Treating Oligometastatic Disease With SABR: More Than Just a Numbers Game?
    Int J Radiat Oncol Biol Phys. 2020;107:257-260.
    PubMed    


  50. PALMA DA, Bauman GS, Rodrigues GB
    Beyond Oligometastases.
    Int J Radiat Oncol Biol Phys. 2020;107:253-256.
    PubMed    


  51. FINAZZI T, Haasbeek CJA, Spoelstra FOB, Palacios MA, et al
    Clinical Outcomes of Stereotactic MR-Guided Adaptive Radiation Therapy for High-Risk Lung Tumors.
    Int J Radiat Oncol Biol Phys. 2020;107:270-278.
    PubMed     Abstract available


  52. AYOUB Z, Ning MS, Brooks ED, Kang J, et al
    Definitive Management of Presumed Synchronous Early Stage Non-Small Cell Lung Cancers: Outcomes and Utility of Stereotactic Ablative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;107:261-269.
    PubMed     Abstract available


    May 2020
  53. HASEGAWA T, Kato T, Naito T, Tanei T, et al
    Long-term outcomes of sporadic vestibular schwannomas treated with recent stereotactic radiosurgery techniques.
    Int J Radiat Oncol Biol Phys. 2020 May 28. pii: S0360-3016(20)31186.
    PubMed     Abstract available


  54. CHU C, Davis CM, Lan X, Hienz RD, et al
    Neuroinflammation following stereotactic radiosurgery-induced brain tumor disintegration is linked to persistent cognitive decline in a mouse model of metastatic disease.
    Int J Radiat Oncol Biol Phys. 2020 May 26. pii: S0360-3016(20)31151.
    PubMed     Abstract available


  55. RAHIMI A, Zhang Y, Kim DW, Morgan H, et al
    Risk factors for fat necrosis after stereotactic partial breast irradiation (S-PBI) for early stage breast cancer in a phase I clinical trial.
    Int J Radiat Oncol Biol Phys. 2020 May 25. pii: S0360-3016(20)31149.
    PubMed     Abstract available


  56. LIU Q, Zhu Z, Chen Y, Deng J, et al
    Phase II Study of SBRT for Patients With Oligometastatic Esophageal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2020 May 14. pii: S0360-3016(20)31127.
    PubMed     Abstract available


  57. KASMANN L, Eze C, Manapov F
    Stereotactic Body Radiation Therapy (SBRT) Combined with Immune Check-Point Inhibition (ICI) in Advanced Lung Cancer: Which Metastatic Site Should Be Irradiated to Induce Immunogenic Cell Death?
    Int J Radiat Oncol Biol Phys. 2020 May 12. pii: S0360-3016(20)30987.
    PubMed    


  58. VAN DE VEN S, van den Bongard D, Pielkenrood B, Kasperts N, et al
    Patient-Reported Outcomes of Oligometastatic Patients After Conventional or Stereotactic Radiation Therapy to Bone Metastases: An Analysis of the PRESENT Cohort.
    Int J Radiat Oncol Biol Phys. 2020;107:39-47.
    PubMed     Abstract available


  59. CHEN WC, Baal JD, Baal U, Pai J, et al
    Stereotactic Body Radiation Therapy of Adrenal Metastases: A Pooled Meta-Analysis and Systematic Review of 39 Studies with 1006 Patients.
    Int J Radiat Oncol Biol Phys. 2020;107:48-61.
    PubMed     Abstract available


  60. ALAYED Y, Davidson M, Liu S, Chu W, et al
    Evaluating the Tolerability of a Simultaneous Focal Boost to the Gross Tumor in Prostate SABR: A Toxicity and Quality-of-Life Comparison of Two Prospective Trials.
    Int J Radiat Oncol Biol Phys. 2020;107:136-142.
    PubMed     Abstract available


  61. GUO T, Ni J, Yang X, Li Y, et al
    Pattern of Recurrence Analysis in Metastatic EGFR-Mutant NSCLC Treated with Osimertinib: Implications for Consolidative Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;107:62-71.
    PubMed     Abstract available


    April 2020
  62. HRYCUSHKO B, van der Kogel AJ, Phillips L, Folkert M, et al
    Existence of a Dose-Length Effect in Spinal Nerves Receiving Single-Session Stereotactic Ablative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;106:1010-1016.
    PubMed     Abstract available


    March 2020
  63. ALBUQUERQUE K, Timmerman R
    In Reply to Dalwadi et al.
    Int J Radiat Oncol Biol Phys. 2020;106:889.
    PubMed    


  64. DALWADI SM, Bonnen MD, Ludwig MS
    In Regard to Albuquerque et al.
    Int J Radiat Oncol Biol Phys. 2020;106:888-889.
    PubMed    


  65. KLEMENT RJ, Sonke JJ, Allgauer M, Andratschke N, et al
    Correlating dose variables with local tumor control in stereotactic body radiotherapy for early stage non-small cell lung cancer: A modelling study on 1500 individual treatments.
    Int J Radiat Oncol Biol Phys. 2020 Mar 15. pii: S0360-3016(20)30897.
    PubMed     Abstract available


  66. KIRKPATRICK JP
    Classifying Leptomeningeal Disease: An Essential Element in Managing Advanced Metastatic Disease in the Central Nervous System.
    Int J Radiat Oncol Biol Phys. 2020;106:587-588.
    PubMed    


  67. VAN MARLEN P, Dahele M, Folkerts M, Abel E, et al
    Bringing FLASH to the Clinic: Treatment Planning Considerations for Ultrahigh Dose-Rate Proton Beams.
    Int J Radiat Oncol Biol Phys. 2020;106:621-629.
    PubMed     Abstract available


  68. SAMPATH S, Frankel P, Vecchio BD, Ruel N, et al
    Stereotactic Body Radiation Therapy to the Prostate Bed: Results of a Phase 1 Dose-Escalation Trial.
    Int J Radiat Oncol Biol Phys. 2020;106:537-545.
    PubMed     Abstract available


  69. REYNOLDS TA, Jensen AR, Bellairs EE, Ozer M, et al
    Dose Gradient Index for Stereotactic Radiosurgery/Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;106:604-611.
    PubMed     Abstract available


  70. KAMRAVA M, Chino JP, Beriwal S
    SAbR as an Alternative Boost Modality for Cervical Cancer: A Cautionary Exercise.
    Int J Radiat Oncol Biol Phys. 2020;106:472-474.
    PubMed    


  71. GIULIANI ME, Robinson CG, Salama JK, Daly ME, et al
    Oligoreview of Non-Small Cell Lung Cancer Oligometastases.
    Int J Radiat Oncol Biol Phys. 2020;106:455-459.
    PubMed    


    February 2020
  72. GIGLIOLI FR, Garibaldi C, Blanck O, Villaggi E, et al
    Dosimetric Multicenter Planning Comparison Studies for Stereotactic Body Radiation Therapy: Methodology and Future Perspectives.
    Int J Radiat Oncol Biol Phys. 2020;106:403-412.
    PubMed     Abstract available


  73. TENDLER II, Hartford A, Jermyn M, LaRochelle E, et al
    Experimentally Observed Cherenkov Light Generation in the Eye During Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;106:422-429.
    PubMed     Abstract available


  74. MACDONALD RL, Lee Y, Schasfoort J, Soliman H, et al
    Real-Time Infrared Motion Tracking Analysis for Patients Treated With Gated Frameless Image Guided Stereotactic Radiosurgery.
    Int J Radiat Oncol Biol Phys. 2020;106:413-421.
    PubMed     Abstract available


  75. TRIFILETTI DM, Ballman KV, Brown PD, Anderson SK, et al
    Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3).
    Int J Radiat Oncol Biol Phys. 2020;106:255-260.
    PubMed     Abstract available


  76. FULLER D, Wurzer J, Shirazi R, Bridge S, et al
    Retreatment for Local Recurrence of Prostatic Carcinoma After Prior Therapeutic Irradiation: Efficacy and Toxicity of HDR-Like SBRT.
    Int J Radiat Oncol Biol Phys. 2020;106:291-299.
    PubMed     Abstract available


  77. REDMOND KJ, Sciubba D, Khan M, Gui C, et al
    A Phase 2 Study of Post-Operative Stereotactic Body Radiation Therapy (SBRT) for Solid Tumor Spine Metastases.
    Int J Radiat Oncol Biol Phys. 2020;106:261-268.
    PubMed     Abstract available


    January 2020
  78. DAUTRUCHE A, Filion E, Mathieu D, Bahig H, et al
    To biopsy or not to biopsy: A matched cohort analysis of early stage lung cancer treated with stereotactic radiation with or without histologic confirmation.
    Int J Radiat Oncol Biol Phys. 2020 Jan 28. pii: S0360-3016(20)30124.
    PubMed     Abstract available


  79. MANYAM BV, Verdecchia K, Videtic GMM, Zhuang T, et al
    Validation of RTOG 0813 Proximal Bronchial Tree Constraints for Pulmonary Toxicity with Stereotactic Body Radiation Therapy for Central Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jan 24. pii: S0360-3016(20)30068.
    PubMed     Abstract available


  80. FARUQI S, Ruschin M, Soliman H, Myrehaug S, et al
    Adverse Radiation Effect After Hypofractionated Stereotactic Radiosurgery in 5 Daily Fractions for Surgical Cavities and Intact Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2020 Jan 9. pii: S0360-3016(19)34476.
    PubMed     Abstract available


  81. SHER DJ, Timmerman RD, Nedzi L, Ding C, et al
    In Reply to Mendenhall et al.
    Int J Radiat Oncol Biol Phys. 2020;106:221.
    PubMed    


  82. MENDENHALL WM, Holtzman AL, Dagan R, Bryant CM, et al
    In Regard to Sher et al.
    Int J Radiat Oncol Biol Phys. 2020;106:220-221.
    PubMed    


  83. MESKO S, Wang H, Tung S, Wang C, et al
    Estimating PTV Margins in Head and Neck Stereotactic Ablative Radiation Therapy (SABR) Through Target Site Analysis of Positioning and Intrafractional Accuracy.
    Int J Radiat Oncol Biol Phys. 2020;106:185-193.
    PubMed     Abstract available


  84. DUIJM M, van der Voort van Zyp NC, van de Vaart P, Oomen-de Hoop E, et al
    Predicting High-Grade Esophagus Toxicity After Treating Central Lung Tumors With Stereotactic Radiation Therapy Using a Normal Tissue Complication Probability Model.
    Int J Radiat Oncol Biol Phys. 2020;106:73-81.
    PubMed     Abstract available


  85. LI R, Shinde A, Novak J, Vapiwala N, et al
    Temporal Trends of Resident Experience in External Beam Radiation Therapy Cases: Analysis of ACGME Case Logs from 2007 to 2018.
    Int J Radiat Oncol Biol Phys. 2020;106:37-42.
    PubMed     Abstract available


    December 2019
  86. RADES D, Cacicedo J, Conde-Moreno AJ, Segedin B, et al
    Precision radiotherapy for metastatic spinal cord compression: Final results of the PRE-MODE Trial.
    Int J Radiat Oncol Biol Phys. 2019 Dec 5. pii: S0360-3016(19)34460.
    PubMed     Abstract available


  87. KIRKPATRICK JP, Fecci PE
    Offer Hypofractionated SRS... If Her Performance Status Is Good.
    Int J Radiat Oncol Biol Phys. 2019;105:940-941.
    PubMed    


  88. LI R, Vora N
    Radiation Therapy for Surgically Resected Brain Metastasis: What Is Your Approach?
    Int J Radiat Oncol Biol Phys. 2019;105:938-939.
    PubMed    


  89. HARDY-ABELOOS C, Lazarev S, Ru M, Kim E, et al
    Safety and Efficacy of Liver Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma After Segmental Transarterial Radioembolization.
    Int J Radiat Oncol Biol Phys. 2019;105:968-976.
    PubMed     Abstract available


  90. OLSON R, Senan S, Harrow S, Gaede S, et al
    Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2019;105:943-947.
    PubMed     Abstract available


    November 2019
  91. SHI S, Sandhu N, Jin MC, Wang E, et al
    Stereotactic radiosurgery for resected brain metastases: single-institutional experience of over 500 cavities.
    Int J Radiat Oncol Biol Phys. 2019 Nov 27. pii: S0360-3016(19)34058.
    PubMed     Abstract available


  92. ALBUQUERQUE K, Tumati V, Lea J, Ahn C, et al
    A Phase II Trial of Stereotactic Ablative Radiotherapy as a Boost for Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2019 Nov 4. pii: S0360-3016(19)33966.
    PubMed     Abstract available


  93. MITIN T, Henry A, Choudhury A, Chen RC, et al
    SBRT for Localized Prostate Cancer: Is it Ready for Take-Off?
    Int J Radiat Oncol Biol Phys. 2019;105:618-620.
    PubMed    


  94. SPENCER K, Velikova G, Henry A, Westhoff P, et al
    Net Pain Relief After Palliative Radiation Therapy for Painful Bone Metastases: A Useful Measure to Reflect Response Duration? A Further Analysis of the Dutch Bone Metastasis Study.
    Int J Radiat Oncol Biol Phys. 2019;105:559-566.
    PubMed     Abstract available


  95. JIANG NY, Dang AT, Yuan Y, Chu FI, et al
    Multi-Institutional Analysis of Prostate-Specific Antigen Kinetics After Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2019;105:628-636.
    PubMed     Abstract available


    October 2019
  96. SHEPARD MJ, Sheehan JP
    The Choice of Postoperative Stereotactic Radiosurgery After Resection of an Isolated Brain Metastasis.
    Int J Radiat Oncol Biol Phys. 2019 Oct 24. pii: S0360-3016(18)30959.
    PubMed    


  97. TURNER BE, Prabhu RS, Burri SH, Brown PD, et al
    Nodular Leptomeningeal Disease - A Distinct Pattern of Recurrence After Post-Resection Stereotactic Radiosurgery for Brain Metastases: A Multi-Institutional Study of Inter-Observer Reliability.
    Int J Radiat Oncol Biol Phys. 2019 Oct 9. pii: S0360-3016(19)33867.
    PubMed     Abstract available


  98. PASQUIER D, Peiffert D, Nickers P, Maingon P, et al
    A multicentre phase II study of hypofractionated stereostatic boost in intermediate risk prostate carcinoma: a 5-year analysis of the CKNO-PRO trial.
    Int J Radiat Oncol Biol Phys. 2019 Oct 8. pii: S0360-3016(19)33863.
    PubMed     Abstract available


  99. KANG J, Ning MS, Feng H, Li H, et al
    Predicting 5-Year Progression and Survival Outcomes for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Ablative Radiotherapy: Development and Validation of Robust Prognostic Nomograms.
    Int J Radiat Oncol Biol Phys. 2019 Oct 3. pii: S0360-3016(19)33861.
    PubMed     Abstract available


  100. MCCLELLAND S 3RD, Saito NG
    An Intracranial Hemorrhage Wrapped in an Enigma.
    Int J Radiat Oncol Biol Phys. 2019;105:242-243.
    PubMed    


  101. ZHANG Y, Schoenhals J, Christie A, Mohamad O, et al
    Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer.
    Int J Radiat Oncol Biol Phys. 2019;105:367-375.
    PubMed     Abstract available


  102. SHEN PC, Chang WC, Lo CH, Yang JF, et al
    Comparison of Stereotactic Body Radiation Therapy and Transarterial Chemoembolization for Unresectable Medium-Sized Hepatocellular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2019;105:307-318.
    PubMed     Abstract available


    September 2019
  103. OZSAHIN M, Slotman BJ, Bourhis J
    Reproductive Viability of Cells Following Preoperative Stereotactic Ablative Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2019;105:233-234.
    PubMed    


  104. YOUNG MR, Decker RH
    SBRT for Early Stage Laryngeal Cancer: Progress, But Not Quite Ready for Prime Time.
    Int J Radiat Oncol Biol Phys. 2019;105:121-123.
    PubMed    


  105. MUELLER AC, Karam SD
    SBRT for Early Stage Larynx: A Go or No Go? It's All in the Delivery.
    Int J Radiat Oncol Biol Phys. 2019;105:119-120.
    PubMed    


  106. KANG BH, Yu T, Kim JH, Park JM, et al
    Early Closure of a Phase 1 Clinical Trial for SABR in Early-Stage Glottic Cancer.
    Int J Radiat Oncol Biol Phys. 2019;105:104-109.
    PubMed     Abstract available


    August 2019
  107. QIAN JM, Yu JB, Mahajan A, Goldberg SB, et al
    Frequent use of local therapy underscores need for multidisciplinary care in the management of patients with melanoma brain metastases treated with PD-1 inhibitors.
    Int J Radiat Oncol Biol Phys. 2019 Aug 31. pii: S0360-3016(19)33742.
    PubMed     Abstract available


  108. NAVARRIA P, Pessina F, Clerici E, Franceschini D, et al
    Surgery followed by hypofractionated radiosurgery on the tumor bed in oligometastatic patients with large brain metastases. Results of a Phase II study.
    Int J Radiat Oncol Biol Phys. 2019 Aug 31. pii: S0360-3016(19)33743.
    PubMed     Abstract available


  109. SINGH AK, Gomez-Suescun JA, Stephans KL, Bogart JA, et al
    One versus three fractions of stereotactic body radiation therapy for peripheral stage I-II non-small cell lung cancer: a randomized, multi-institution, phase 2 trial.
    Int J Radiat Oncol Biol Phys. 2019 Aug 22. pii: S0360-3016(19)33653.
    PubMed     Abstract available


  110. LIU C, Sun B, Hu X, Zhang Y, et al
    Stereotactic ablative radiotherapy for pulmonary recurrence-based oligometastatic non-small cell lung cancer: survival and prognostic value of regulatory T cells.
    Int J Radiat Oncol Biol Phys. 2019 Aug 19. pii: S0360-3016(19)33646.
    PubMed     Abstract available


  111. BRUYNZEEL AME, Tetar SU, Oei SS, Senan S, et al
    A prospective single-arm phase II study of stereotactic magnetic-resonance-guided adaptive radiotherapy for prostate cancer: Early toxicity results.
    Int J Radiat Oncol Biol Phys. 2019 Aug 13. pii: S0360-3016(19)33640.
    PubMed     Abstract available


  112. DEEK MP, Yu C, Phillips R, Song DY, et al
    Radiotherapy In The Definitive Management Of Oligometastatic Prostate Cancer: The Johns Hopkins Experience.
    Int J Radiat Oncol Biol Phys. 2019 Aug 13. pii: S0360-3016(19)33641.
    PubMed     Abstract available


  113. RADES D, Segedin B, Conde-Moreno AJ, Ferrer-Albiach C, et al
    Patient-reported outcomes - secondary analysis of the SCORE-2 trial comparing 4Gy x 5 to 3Gy x 10 for metastatic epidural spinal cord compression.
    Int J Radiat Oncol Biol Phys. 2019 Aug 12. pii: S0360-3016(19)33634.
    PubMed     Abstract available


  114. KNUTSON NC, Samson PP, Hugo GD, Goddu SM, et al
    Radiation Therapy Workflow and Dosimetric Analysis from a Phase 1/2 Trial of Noninvasive Cardiac Radioablation for Ventricular Tachycardia.
    Int J Radiat Oncol Biol Phys. 2019;104:1114-1123.
    PubMed     Abstract available


  115. ONG WL, Foroudi F, Milne RL, Millar JL, et al
    Are We Choosing Wisely in Radiation Oncology Practice-Findings From an Australian Population-Based Study.
    Int J Radiat Oncol Biol Phys. 2019;104:1012-1016.
    PubMed     Abstract available


    July 2019
  116. PASQUIER D, Martinage G, Janoray G, Rojas DP, et al
    Salvage stereotactic body radiotherapy for local prostate cancer recurrence after radiotherapy: a retrospective multicentre study of the GETUG.
    Int J Radiat Oncol Biol Phys. 2019 Jul 22. pii: S0360-3016(19)33494.
    PubMed     Abstract available


  117. MOHIDEEN N, Kavanagh BD
    Model Insurance Coverage Policies: The Power of Suggestion, the Force of Evidence.
    Int J Radiat Oncol Biol Phys. 2019;104:745-747.
    PubMed    


  118. HRYCUSHKO B, van der Kogel AJ, Phillips L, Folkert MR, et al
    Spinal Nerve Tolerance to Single-Session Stereotactic Ablative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2019;104:845-851.
    PubMed     Abstract available


  119. SUNDAHL N, Seremet T, Van Dorpe J, Neyns B, et al
    Phase 2 Trial of Nivolumab Combined With Stereotactic Body Radiation Therapy in Patients With Metastatic or Locally Advanced Inoperable Melanoma.
    Int J Radiat Oncol Biol Phys. 2019;104:828-835.
    PubMed     Abstract available


  120. FINAZZI T, Palacios MA, Spoelstra FOB, Haasbeek CJA, et al
    Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors.
    Int J Radiat Oncol Biol Phys. 2019;104:933-941.
    PubMed     Abstract available


  121. ROACH MC, Thomas TO, Paravati AJ, Mahajan A, et al
    Differences in United States Insurance Payer Policies and American Society for Radiation Oncology's (ASTRO) Model Policy on Stereotactic Body Radiation Therapy (SBRT).
    Int J Radiat Oncol Biol Phys. 2019;104:740-744.
    PubMed     Abstract available


  122. NGUYEN TK, Sahgal A, Detsky J, Soliman H, et al
    Single-Fraction Stereotactic Radiosurgery vs. Hippocampal-Avoidance Whole Brain Radiotherapy for Patients with 10-30 Brain Metastases: A Dosimetric Analysis.
    Int J Radiat Oncol Biol Phys. 2019 Jul 5. pii: S0360-3016(19)33443.
    PubMed     Abstract available


  123. JACKSON WC, Cuneo KC, Lawrence TS, Owen D, et al
    In Reply to Slovak et al.
    Int J Radiat Oncol Biol Phys. 2019;104:696-697.
    PubMed    


  124. WANG TJC
    Hypofractionated Radiation Therapy or Staged Stereotactic Radiosurgery for Large Brain Metastasis.
    Int J Radiat Oncol Biol Phys. 2019;104:484-485.
    PubMed    


  125. MENZEL P, Theodosopoulos P
    A Caudate Conundrum.
    Int J Radiat Oncol Biol Phys. 2019;104:481-482.
    PubMed    


  126. SAMPATH S, Rahmanuddin S, Sahoo P, Frankel P, et al
    Change in apparent diffusion coefficient is associated with local failure after stereotactic body radiation therapy for non-small cell lung cancer: a prospective clinical trial.
    Int J Radiat Oncol Biol Phys. 2019 Jul 1. pii: S0360-3016(19)33424.
    PubMed     Abstract available


    June 2019
  127. VIDETIC GM
    In Reply to Yilmaz et al.
    Int J Radiat Oncol Biol Phys. 2019;104:467.
    PubMed    


  128. YILMAZ MT, Hurmuz P, Cengiz M
    In Regard to Videtic et al.
    Int J Radiat Oncol Biol Phys. 2019;104:466-467.
    PubMed    


  129. LAVIGNE J, Suissa A, Verger N, Dos Santos M, et al
    Lung Stereotactic Arc Therapy in Mice: Development of Radiation Pneumopathy and Influence of HIF-1alpha Endothelial Deletion.
    Int J Radiat Oncol Biol Phys. 2019;104:279-290.
    PubMed     Abstract available


    May 2019
  130. YUAN Y, Aghdam N, King C, Fuller D, et al
    Testosterone Levels and Sexual Quality of Life Following Stereotactic Body Radiotherapy for Prostate Cancer: A Multi-Institutional Analysis of Prospective Trials.
    Int J Radiat Oncol Biol Phys. 2019 May 17. pii: S0360-3016(19)30727.
    PubMed     Abstract available


  131. WARDAK Z, Bland R, Ahn C, Xie XJ, et al
    A Phase 2 Clinical Trial of SABR Followed by Immediate Vertebroplasty for Spine Metastases.
    Int J Radiat Oncol Biol Phys. 2019;104:83-89.
    PubMed     Abstract available


  132. ZHU X, Ju X, Cao Y, Shen Y, et al
    Patterns of Local Failure After Stereotactic Body Radiation Therapy and Sequential Chemotherapy as Initial Treatment for Pancreatic Cancer: Implications of Target Volume Design.
    Int J Radiat Oncol Biol Phys. 2019;104:101-110.
    PubMed     Abstract available


  133. FRANCESCHINI D, De Rose F, Franzese C, Comito T, et al
    Predictive Factors for Response and Survival in a Cohort of Oligometastatic Patients Treated With Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2019;104:111-121.
    PubMed     Abstract available


  134. BALLAS LK, Luo C, Chung E, Kishan AU, et al
    Phase 1 Trial of SBRT to the Prostate Fossa After Prostatectomy.
    Int J Radiat Oncol Biol Phys. 2019;104:50-60.
    PubMed     Abstract available


    April 2019
  135. ALAYED Y, Loblaw A, Chu W, Al-Hanaqta M, et al
    Stereotactic Body Radiotherapy Boost for Intermediate Risk Prostate Cancer: A Phase 1 Dose Escalation Study.
    Int J Radiat Oncol Biol Phys. 2019 Apr 16. pii: S0360-3016(19)30624.
    PubMed     Abstract available


  136. JACKSON WC, Silva J, Hartman HE, Dess RT, et al
    Stereotactic Body Radiotherapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies.
    Int J Radiat Oncol Biol Phys. 2019 Apr 5. pii: S0360-3016(19)30612.
    PubMed     Abstract available


  137. HUGHES RT, Masters AH, McTyre ER, Farris MK, et al
    Initial SRS for patients with 5-15 brain metastases: results of a multi-institutional experience.
    Int J Radiat Oncol Biol Phys. 2019 Apr 5. pii: S0360-3016(19)30613.
    PubMed     Abstract available


  138. SIVA S, Ball DL
    Single Fraction SBRT for Early Stage Lung Cancer-Less is More?
    Int J Radiat Oncol Biol Phys. 2019;103:1085-1087.
    PubMed    


  139. RUSTHOVEN CG
    Small Cell Lung Cancer: PCI Uncertainty and Emerging Radiosurgery Interest.
    Int J Radiat Oncol Biol Phys. 2019;103:1034-1035.
    PubMed    


  140. GASPAR LE
    A Gray Zone Regarding Gray Matter.
    Int J Radiat Oncol Biol Phys. 2019;103:1033-1034.
    PubMed    


  141. WEGNER RE, Hasan S
    Observe the Brain and Preserve the Mind.
    Int J Radiat Oncol Biol Phys. 2019;103:1033.
    PubMed    


  142. SHINDE A, Amini A
    Challenging Current Conventions: Up-Front Stereotactic Radiosurgery Alone for Limited Brain Metastases in Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2019;103:1031-1032.
    PubMed    


  143. ADAMSON J, Carroll J, Trager M, Yoon SW, et al
    Delivered Dose Distribution Visualized Directly With Onboard kV-CBCT: Proof of Principle.
    Int J Radiat Oncol Biol Phys. 2019;103:1271-1279.
    PubMed     Abstract available


    March 2019
  144. PALMA D, Daly M, Urbanic J, Giuliani M, et al
    Stereotactic Radiation for Ultra-Central Lung Tumors: Good Idea, or Ultra-Risky?
    Int J Radiat Oncol Biol Phys. 2019;103:788-791.
    PubMed    


  145. MCCLELLAND S 3RD, Watson GA
    Impact of MRI Timing on Accuracy of Stereotactic Radiosurgical Planning: Visualizing the Forest From the Trees.
    Int J Radiat Oncol Biol Phys. 2019;103:1012-1013.
    PubMed    


  146. MA JT, Liu Y, Sun L, Milano MT, et al
    Chest Wall Toxicity After Stereotactic Body Radiation Therapy: A Pooled Analysis of 57 Studies.
    Int J Radiat Oncol Biol Phys. 2019;103:843-850.
    PubMed     Abstract available


  147. SHER DJ, Timmerman RD, Nedzi L, Ding C, et al
    Phase I fractional dose escalation study of equipotent stereotactic radiotherapy regimens for early-stage glottic larynx cancer.
    Int J Radiat Oncol Biol Phys. 2019 Mar 14. pii: S0360-3016(19)30323.
    PubMed     Abstract available


  148. MIYAWAKI E, Kenmotsu H, Mori K, Harada H, et al
    Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-mutant NSCLC with Brain Metastases Stratified by Number of Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2019 Mar 6. pii: S0360-3016(19)30307.
    PubMed     Abstract available


  149. VERNIMMEN FJ, Fredericks S, Wallace ND, Fitzgerald AP, et al
    Long-Term Follow-up of Patients Treated at a Single Institution Using a Passively Scattered Proton Beam; Observations Around the Occurrence of Second Malignancies.
    Int J Radiat Oncol Biol Phys. 2019;103:680-685.
    PubMed     Abstract available


  150. MARCROM SR, Kahn JM, Colbert LE, Freese CM, et al
    Brachytherapy Training Survey of Radiation Oncology Residents.
    Int J Radiat Oncol Biol Phys. 2019;103:557-560.
    PubMed     Abstract available


  151. RAO AD, Ladra M, Dunn E, Kumar R, et al
    A Road Map for Important Centers of Growth in the Pediatric Skeleton to Consider During Radiation Therapy and Associated Clinical Correlates of Radiation-Induced Growth Toxicity.
    Int J Radiat Oncol Biol Phys. 2019;103:669-679.
    PubMed     Abstract available


    February 2019
  152. D'AGOSTINO GR, di Brina L, Mancosu P, Franzese C, et al
    Re-Irradiation of Locally Recurrent Prostate Cancer with Volumetric Modulated Arc Therapy (Vmat).
    Int J Radiat Oncol Biol Phys. 2019 Feb 27. pii: S0360-3016(19)30285.
    PubMed     Abstract available


  153. POTTERS L, Rana Z, Lee L, Cox BW, et al
    Outcomes of a Dose-Escalated Stereotactic Body Radiation Phase I/II trial for Patients with Low and Intermediate-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2019 Feb 2. pii: S0360-3016(19)30183.
    PubMed     Abstract available


  154. HERRERA FG, Valerio M, Berthold D, Tawadros T, et al
    50-Gy Stereotactic Body Radiation Therapy to the Dominant Intraprostatic Nodule: Results From a Phase 1a/b Trial.
    Int J Radiat Oncol Biol Phys. 2019;103:320-334.
    PubMed     Abstract available


  155. FAST M, van de Schoot A, van de Lindt T, Carbaat C, et al
    Tumor Trailing for Liver SBRT on the MR-Linac.
    Int J Radiat Oncol Biol Phys. 2019;103:468-478.
    PubMed     Abstract available


    January 2019
  156. ZELEFSKY MJ, Kollmeier M, McBride S, Varghese M, et al
    5-Year Outcomes of a Phase I Dose Escalation Study Using Stereotactic Body Radiosurgery for Patients with Low and Intermediate Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2019 Jan 3. pii: S0360-3016(18)34227.
    PubMed     Abstract available


  157. SAHGAL A
    Lead with Surgery, SBRT to Follow.
    Int J Radiat Oncol Biol Phys. 2019;103:16-17.
    PubMed    


  158. MENDIRATTA-LALA M, Masch W, Shankar PR, Hartman HE, et al
    Magnetic Resonance Imaging Evaluation of Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy: Long Term Imaging Follow-Up.
    Int J Radiat Oncol Biol Phys. 2019;103:169-179.
    PubMed     Abstract available


  159. STAM B, Kwint M, Guckenberger M, Mantel F, et al
    Subgroup Survival Analysis in Stage I-II NSCLC Patients With a Central Tumor Partly Treated With Risk-Adapted SBRT.
    Int J Radiat Oncol Biol Phys. 2019;103:132-141.
    PubMed     Abstract available


  160. SUTERA P, Clump DA, Kalash R, D'Ambrosio D, et al
    Initial Results of a Multicenter Phase 2 Trial of Stereotactic Ablative Radiation Therapy for Oligometastatic Cancer.
    Int J Radiat Oncol Biol Phys. 2019;103:116-122.
    PubMed     Abstract available


  161. VINOGRADSKIY Y, Goodman KA, Schefter T, Miften M, et al
    The Clinical and Dosimetric Impact of Real-Time Target Tracking in Pancreatic SBRT.
    Int J Radiat Oncol Biol Phys. 2019;103:268-275.
    PubMed     Abstract available


  162. HOF SV, Delaney AR, Tekatli H, Twisk J, et al
    Knowledge-Based Planning for Identifying High-Risk Stereotactic Ablative Radiation Therapy Treatment Plans for Lung Tumors Larger Than 5 cm.
    Int J Radiat Oncol Biol Phys. 2019;103:259-267.
    PubMed     Abstract available


    December 2018
  163. VIDETIC GM, Paulus R, Singh AK, Chang JY, et al
    Long term follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A randomized phase II study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2018 Dec 1. pii: S0360-3016(18)34048.
    PubMed     Abstract available


    November 2018
  164. PENG L, Parekh V, Huang P, Lin DD, et al
    Distinguishing True Progression From Radionecrosis After Stereotactic Radiation Therapy for Brain Metastases With Machine Learning and Radiomics.
    Int J Radiat Oncol Biol Phys. 2018;102:1236-1243.
    PubMed     Abstract available


  165. ALAYED Y, Cheung P, Vesprini D, Liu S, et al
    SABR in high risk prostate cancer: outcomes from two prospective clinical trials with and without elective nodal irradiation.
    Int J Radiat Oncol Biol Phys. 2018 Nov 13. pii: S0360-3016(18)33997.
    PubMed     Abstract available


  166. YAMAMOTO M, Aiyama H, Koiso T, Watanabe S, et al
    Validity of a Recently-Proposed Prognostic Grading Index, Brain Metastasis Velocity, for Brain Metastasis Patients Undergoing Multiple Radiosurgical Procedures.
    Int J Radiat Oncol Biol Phys. 2018 Nov 2. pii: S0360-3016(18)33925.
    PubMed     Abstract available


  167. LEHRER EJ, Peterson JL, Zaorsky NG, Brown PD, et al
    Single versus multifraction stereotactic radiosurgery for large brain metastases: An international meta-analysis of 24 trials.
    Int J Radiat Oncol Biol Phys. 2018 Nov 2. pii: S0360-3016(18)33927.
    PubMed     Abstract available


  168. FRICK MA, Kao GD, Aguarin L, Chinniah C, et al
    Circulating Tumor Cell Assessment in Presumed Early Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy: A Prospective Pilot Study.
    Int J Radiat Oncol Biol Phys. 2018;102:536-542.
    PubMed     Abstract available


    October 2018
  169. BONDIAU PY, Gal J, Chapellier C, Haudebourg J, et al
    Robotic stereotactic boost in early breast cancer, a phase II trial.
    Int J Radiat Oncol Biol Phys. 2018 Oct 26. pii: S0360-3016(18)33799.
    PubMed     Abstract available


  170. VANDERSTRAETEN B, Goddeeris B, Vandecasteele K, van Eijkeren M, et al
    Automated Instead of Manual Treatment Planning? A Plan Comparison Based on Dose-Volume Statistics and Clinical Preference.
    Int J Radiat Oncol Biol Phys. 2018;102:443-450.
    PubMed     Abstract available


  171. MEIER RM, Bloch DA, Cotrutz C, Beckman AC, et al
    Multicenter Trial of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: Survival and Toxicity Endpoints.
    Int J Radiat Oncol Biol Phys. 2018;102:296-303.
    PubMed     Abstract available


  172. PALACIOS MA, Bohoudi O, Bruynzeel AME, van Sorsen de Koste JR, et al
    Role of Daily Plan Adaptation in MR-Guided Stereotactic Ablative Radiation Therapy for Adrenal Metastases.
    Int J Radiat Oncol Biol Phys. 2018;102:426-433.
    PubMed     Abstract available


    September 2018
  173. EVANS JD, Morris LK, Zhang H, Cao S, et al
    Prospective Immunophenotyping of CD8(+) T-cells and Associated Clinical Outcomes of Patients with Oligometastatic Prostate Cancer Treated with Metastasis-Directed SBRT.
    Int J Radiat Oncol Biol Phys. 2018 Sep 8. pii: S0360-3016(18)33725.
    PubMed     Abstract available


  174. KELADA OJ, Decker RH, Nath SK, Johung KL, et al
    High Single Doses of Radiation May Induce Elevated Levels of Hypoxia in Early-Stage Non-Small Cell Lung Cancer Tumors.
    Int J Radiat Oncol Biol Phys. 2018;102:174-183.
    PubMed     Abstract available


    August 2018
  175. GHIA AJ, Guha-Thakurta N, Hess K, Yang JN, et al
    Phase 1 study of spinal cord constraint relaxation with single session spine stereotactic radiosurgery in the primary management of patients with inoperable, previously unirradiated metastatic epidural spinal cord compression.
    Int J Radiat Oncol Biol Phys. 2018 Aug 9. pii: S0360-3016(18)33524.
    PubMed     Abstract available


    July 2018
  176. MUSUNURU HB, D'Alimonte L, Davidson M, Ho L, et al
    Phase I/II Study of Stereotactic Ablative Radiotherapy Including Regional Lymph Node Irradiation in Patients with High-Risk Prostate Cancer (SATURN): Early Toxicity and Quality of Life.
    Int J Radiat Oncol Biol Phys. 2018 Jul 30. pii: S0360-3016(18)33462.
    PubMed     Abstract available


  177. KIRKPATRICK JP, Laack NN, Halasz LM, Minniti G, et al
    Proton Therapy for Brain Metastases: A Question of Value.
    Int J Radiat Oncol Biol Phys. 2018;101:830-832.
    PubMed    


  178. SPERDUTO PW, Deegan BJ, Li J, Jethwa KR, et al
    Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2018;101:845-853.
    PubMed     Abstract available


  179. LOCKNEY NA, Wang DG, Pei X, Goldman DA, et al
    Phosphatidylinositol-3-Kinase Mutations Are Associated With Increased Local Failure in Brain Metastases Treated With Radiation.
    Int J Radiat Oncol Biol Phys. 2018;101:833-844.
    PubMed     Abstract available


  180. ATKINS KM, Pashtan IM, Bussiere MR, Kang KH, et al
    Proton Stereotactic Radiosurgery for Brain Metastases: A Single-Institution Analysis of 370 Patients.
    Int J Radiat Oncol Biol Phys. 2018;101:820-829.
    PubMed     Abstract available


  181. PETTY WJ, Urbanic JJ, Ahmed T, Hughes R, et al
    Long Term Outcomes of a Phase II Trial of Chemotherapy with Consolidative Radiation Therapy for Oligometastatic Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2018 Jul 9. pii: S0360-3016(18)31401.
    PubMed     Abstract available


  182. HURMUZ P, Ozyigit G
    In Regard to Nantavithya et al.
    Int J Radiat Oncol Biol Phys. 2018;101:744-745.
    PubMed    


  183. SARKAR B
    In Regard to Dong et al.
    Int J Radiat Oncol Biol Phys. 2018;101:741-742.
    PubMed    


  184. LAZZARI R, Ronchi S, Gandini S, Surgo A, et al
    Stereotactic Body Radiation Therapy for Oligometastatic Ovarian Cancer: A Step Toward a Drug Holiday.
    Int J Radiat Oncol Biol Phys. 2018;101:650-660.
    PubMed     Abstract available


    June 2018
  185. LIN AJ, Hui C, Dahiya S, Lu HC, et al
    Radiologic Response and Disease Control of Recurrent Intracranial Meningiomas Treated With Reirradiation.
    Int J Radiat Oncol Biol Phys. 2018 Jun 30. pii: S0360-3016(18)30804.
    PubMed     Abstract available


  186. SALKELD AL, Hau EKC, Nahar N, Sykes JR, et al
    Changes in brain metastasis during radiosurgical planning.
    Int J Radiat Oncol Biol Phys. 2018 Jun 25. pii: S0360-3016(18)31012.
    PubMed     Abstract available


  187. NATARAJAN B, Spiegel D, Nichols EM, Feigenberg S, et al
    Findings on Surveillance Imaging After Preoperative Partial Breast Irradiation for Early Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2018 Jun 5. pii: S0360-3016(18)30911.
    PubMed     Abstract available


  188. MILANO MT, Sharma M, Soltys SG, Sahgal A, et al
    Radiation-Induced Edema After Single-Fraction or Multifraction Stereotactic Radiosurgery for Meningioma: A Critical Review.
    Int J Radiat Oncol Biol Phys. 2018;101:344-357.
    PubMed     Abstract available


  189. SARRIA GJ, Saria GR, Pinillos LV
    The Inca Trail to the Present: The Development of Radiation Therapy in Peru.
    Int J Radiat Oncol Biol Phys. 2018;101:244-249.
    PubMed    


  190. WORM ES, Hoyer M, Hansen R, Larsen LP, et al
    A Prospective Cohort Study of Gated Stereotactic Liver Radiation Therapy Using Continuous Internal Electromagnetic Motion Monitoring.
    Int J Radiat Oncol Biol Phys. 2018;101:366-375.
    PubMed     Abstract available


    May 2018
  191. WANG HH, Wu ZQ, Qian D, Zaorsky NG, et al
    Ablative Hypofractionated Radiation Therapy Enhances Non-Small Cell Lung Cancer Cell Killing via Preferential Stimulation of Necroptosis In Vitro and In Vivo.
    Int J Radiat Oncol Biol Phys. 2018;101:49-62.
    PubMed     Abstract available


  192. SPERDUTO PW
    In Regard to Churilla et al.
    Int J Radiat Oncol Biol Phys. 2018;101:238-239.
    PubMed    


  193. CHEN H, Laba JM, Boldt RG, Goodman CD, et al
    Stereotactic Ablative Radiation Therapy Versus Surgery in Early Lung Cancer: A Meta-analysis of Propensity Score Studies.
    Int J Radiat Oncol Biol Phys. 2018;101:186-194.
    PubMed     Abstract available


  194. GEBHARDT BJ, Vargo JA, Ling D, Jones B, et al
    Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018;101:195-200.
    PubMed     Abstract available


    April 2018
  195. SONG D
    Apply an Oligometastatic Paradigm for Nodal Recurrence.
    Int J Radiat Oncol Biol Phys. 2018;100:1098-1099.
    PubMed    


  196. TRAN PT, Feng F, Ost P
    Live to SABR Another Day?
    Int J Radiat Oncol Biol Phys. 2018;100:1097.
    PubMed    


  197. SHINTANI T, Matsuo Y, Iizuka Y, Mitsuyoshi T, et al
    A Retrospective Long-term Follow-up Study of Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer From a Single Institution: Incidence of Late Local Recurrence.
    Int J Radiat Oncol Biol Phys. 2018;100:1228-1236.
    PubMed     Abstract available


  198. TOESCA DAS, Koong AJ, Poultsides GA, Visser BC, et al
    Management of Borderline Resectable Pancreatic Cancer.
    Int J Radiat Oncol Biol Phys. 2018;100:1155-1174.
    PubMed     Abstract available


  199. STEVERINK JG, Willems SM, Philippens MEP, Kasperts N, et al
    Early Tissue Effects of Stereotactic Body Radiation Therapy for Spinal Metastases.
    Int J Radiat Oncol Biol Phys. 2018;100:1254-1258.
    PubMed     Abstract available


    March 2018
  200. SCHAPIRA E, Hubbeling H, Yeap BY, Mehan WA Jr., et al
    Improved Overall Survival and Locoregional Disease Control With Concurrent PD-1 Pathway Inhibitors and Stereotactic Radiosurgery for Lung Cancer Patients With Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2018 Mar 22. pii: S0360-3016(18)30542.
    PubMed     Abstract available


  201. JACKSON WC, Tao Y, Mendiratta-Lala M, Bazzi L, et al
    Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases.
    Int J Radiat Oncol Biol Phys. 2018;100:950-958.
    PubMed     Abstract available


  202. CHEN L, Douglass J, Kleinberg L, Ye X, et al
    Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2018;100:916-925.
    PubMed     Abstract available


  203. SUNDAHL N, De Wolf K, Kruse V, Meireson A, et al
    Phase 1 Dose Escalation Trial of Ipilimumab and Stereotactic Body Radiation Therapy in Metastatic Melanoma.
    Int J Radiat Oncol Biol Phys. 2018;100:906-915.
    PubMed     Abstract available


  204. YOUNGE KC, Marsh RB, Owen D, Geng H, et al
    Improving Quality and Consistency in NRG Oncology Radiation Therapy Oncology Group 0631 for Spine Radiosurgery via Knowledge-Based Planning.
    Int J Radiat Oncol Biol Phys. 2018;100:1067-1074.
    PubMed     Abstract available


  205. NANTAVITHYA C, Gomez DR, Wei X, Komaki R, et al
    Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2018 Mar 2. pii: S0360-3016(18)30316.
    PubMed     Abstract available


  206. MINNITI G, Soltys SG, Halasz LM, Breneman JC, et al
    Stereotactic Radiosurgery for Resected Brain Metastases: New Evidence Supports a Practice Shift, but Questions Remain.
    Int J Radiat Oncol Biol Phys. 2018;100:535-538.
    PubMed    


  207. TEKATLI H, Duijm M, Oomen-de Hoop E, Verbakel W, et al
    Normal Tissue Complication Probability Modeling of Pulmonary Toxicity After Stereotactic and Hypofractionated Radiation Therapy for Central Lung Tumors.
    Int J Radiat Oncol Biol Phys. 2018;100:738-747.
    PubMed     Abstract available


  208. GALLE JO, Long DE, Lautenschlaeger T, Zellars RC, et al
    Effects of Proton Center Closure on Pediatric Case Volume and Resident Education at an Academic Cancer Center.
    Int J Radiat Oncol Biol Phys. 2018;100:710-718.
    PubMed     Abstract available


  209. NABAVIZADEH N, Waller JG, Fain R 3rd, Chen Y, et al
    Safety and Efficacy of Accelerated Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Varying Degrees of Hepatic Impairment.
    Int J Radiat Oncol Biol Phys. 2018;100:577-585.
    PubMed     Abstract available


    February 2018
  210. CYSOUW M, Bouman-Wammes E, Hoekstra O, van den Eertwegh A, et al
    Prognostic Value of [(18)F]-Fluoromethylcholine Positron Emission Tomography/Computed Tomography Before Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2018 Feb 13. pii: S0360-3016(18)30252.
    PubMed     Abstract available


  211. STEPHANS KL, Woody NM, Reddy CA, Varley M, et al
    Tumor Control and Toxicity for Common Stereotactic Body Radiation Therapy Dose-Fractionation Regimens in Stage I Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2018;100:462-469.
    PubMed     Abstract available


  212. RAO AD, Liu Y, von Eyben R, Hsu CC, et al
    Multiplex Proximity Ligation Assay to Identify Potential Prognostic Biomarkers for Improved Survival in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2018;100:486-489.
    PubMed     Abstract available


    January 2018
  213. SURESH K, Owen D, Bazzi L, Jackson W, et al
    Using Indocyanine Green Extraction to Predict Liver Function After Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2018;100:131-137.
    PubMed     Abstract available


  214. ITO K, Shimizuguchi T, Nihei K, Furuya T, et al
    Patterns of Intraosseous Recurrence After Stereotactic Body Radiation Therapy for Coxal Bone Metastasis.
    Int J Radiat Oncol Biol Phys. 2018;100:159-161.
    PubMed     Abstract available


  215. SAPIR E, Tao Y, Schipper MJ, Bazzi L, et al
    Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2018;100:122-130.
    PubMed     Abstract available


    December 2017
  216. BERNARD V, Bishop AJ, Allen PK, Amini B, et al
    Heterogeneity in Treatment Response of Spine Metastases to Spine Stereotactic Radiosurgery Within "Radiosensitive" Subtypes.
    Int J Radiat Oncol Biol Phys. 2017;99:1207-1215.
    PubMed     Abstract available


  217. KELLER A, Dore M, Cebula H, Thillays F, et al
    Hypofractionated Stereotactic Radiation Therapy to the Resection Bed for Intracranial Metastases.
    Int J Radiat Oncol Biol Phys. 2017;99:1179-1189.
    PubMed     Abstract available


    November 2017
  218. JOO JH, Park JH, Kim JC, Yu CS, et al
    Local Control Outcomes Using Stereotactic Body Radiation Therapy for Liver Metastases From Colorectal Cancer.
    Int J Radiat Oncol Biol Phys. 2017;99:876-883.
    PubMed     Abstract available


  219. KOONTZ BF
    Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer: The Hunt for the Silver Bullet.
    Int J Radiat Oncol Biol Phys. 2017;99:761-763.
    PubMed    


  220. KUMAR S, Feddock J, Li X, Shearer AJ, et al
    Update of a Prospective Study of Stereotactic Body Radiation Therapy for Post-Chemoradiation Residual Disease in Stage II/III Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;99:652-659.
    PubMed     Abstract available


    October 2017
  221. SOLIMAN H, Ruschin M, Angelov L, Brown PD, et al
    Consensus Contouring Guidelines for Postoperative Completely Resected Cavity Stereotactic Radiosurgery for Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2017 Oct 4. pii: S0360-3016(17)33953.
    PubMed     Abstract available


  222. PRABHU RS, Press RH, Patel KR, Boselli DM, et al
    Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.
    Int J Radiat Oncol Biol Phys. 2017;99:459-467.
    PubMed     Abstract available


  223. MCPARTLIN A, Swaminath A, Wang R, Pintilie M, et al
    Long-Term Outcomes of Phase 1 and 2 Studies of SBRT for Hepatic Colorectal Metastases.
    Int J Radiat Oncol Biol Phys. 2017;99:388-395.
    PubMed     Abstract available


  224. BAHIG H, Campeau MP, Lapointe A, Bedwani S, et al
    Phase 1-2 Study of Dual-Energy Computed Tomography for Assessment of Pulmonary Function in Radiation Therapy Planning.
    Int J Radiat Oncol Biol Phys. 2017;99:334-343.
    PubMed     Abstract available


    September 2017
  225. RONDEN MI, van Sornsen de Koste JR, Johnson C, Slotman BJ, et al
    Incidence of High-Risk Radiologic Features in Patients Without Local Recurrence After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Sep 22. pii: S0360-3016(17)33935.
    PubMed     Abstract available


  226. LO A, Ayre G, Ma R, Hsu F, et al
    Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities.
    Int J Radiat Oncol Biol Phys. 2017 Sep 18. pii: S0360-3016(17)33891.
    PubMed     Abstract available


  227. YAMAMOTO M, Serizawa T, Higuchi Y, Sato Y, et al
    A Multi-institutional Prospective Observational Study of Stereotactic Radiosurgery for Patients With Multiple Brain Metastases (JLGK0901 Study Update): Irradiation-related Complications and Long-term Maintenance of Mini-Mental State Examination Scores
    Int J Radiat Oncol Biol Phys. 2017;99:31-40.
    PubMed     Abstract available


  228. WILLIAMS NL, Wuthrick EJ, Kim H, Palmer JD, et al
    Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2017;99:22-30.
    PubMed     Abstract available


  229. WU CC, Chaudhary KR, Na YH, Welch D, et al
    Quality Assessment of Stereotactic Radiosurgery of a Melanoma Brain Metastases Model Using a Mouselike Phantom and the Small Animal Radiation Research Platform.
    Int J Radiat Oncol Biol Phys. 2017;99:191-201.
    PubMed     Abstract available


  230. CHOI CYH, Wakelee HA, Neal JW, Pinder-Schenck MC, et al
    Vorinostat and Concurrent Stereotactic Radiosurgery for Non-Small Cell Lung Cancer Brain Metastases: A Phase 1 Dose Escalation Trial.
    Int J Radiat Oncol Biol Phys. 2017;99:16-21.
    PubMed     Abstract available


  231. LO CH, Liu MY, Lee MS, Yang JF, et al
    Comparison Between Child-Turcotte-Pugh and Albumin-Bilirubin Scores in Assessing the Prognosis of Hepatocellular Carcinoma After Stereotactic Ablative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;99:145-152.
    PubMed     Abstract available


    August 2017
  232. CHURILLA TM, Ballman KV, Brown PD, Twohy EL, et al
    Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2017 Aug 5. pii: S0360-3016(17)33691.
    PubMed     Abstract available


  233. WERNICKE AG, Hirschfeld CB, Smith AW, Taube S, et al
    Clinical Outcomes of Large Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial.
    Int J Radiat Oncol Biol Phys. 2017;98:1059-1068.
    PubMed     Abstract available


  234. SHAVERDIAN N, Yoo SM, Cook R, Chang EM, et al
    Gaps in Radiation Therapy Awareness: Results From an Educational Multi-institutional Survey of US Internal Medicine Residents.
    Int J Radiat Oncol Biol Phys. 2017;98:1153-1161.
    PubMed     Abstract available


  235. KOTECHA R, Miller JA, Modugula S, Barnett GH, et al
    Stereotactic Radiosurgery for Trigeminal Neuralgia Improves Patient-Reported Quality of Life and Reduces Depression.
    Int J Radiat Oncol Biol Phys. 2017;98:1078-1086.
    PubMed     Abstract available


    July 2017
  236. CHEN L, Shen C, Redmond KJ, Page BR, et al
    Use of Stereotactic Radiosurgery in Elderly and Very Elderly Patients With Brain Metastases to Limit Toxicity Associated With Whole Brain Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;98:939-947.
    PubMed     Abstract available


  237. PRESS RH, Boselli DM, Symanowski JT, Lankford SP, et al
    External Validity of a Risk Stratification Score Predicting Early Distant Brain Failure and Salvage Whole Brain Radiation Therapy After Stereotactic Radiosurgery for Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2017;98:632-638.
    PubMed     Abstract available


  238. CHEN H, Senan S, Nossent EJ, Boldt RG, et al
    Treatment-Related Toxicity in Patients With Early-Stage Non-Small Cell Lung Cancer and Coexisting Interstitial Lung Disease: A Systematic Review.
    Int J Radiat Oncol Biol Phys. 2017;98:622-631.
    PubMed     Abstract available


  239. RUSCHIN M, Sahgal A, Tseng CL, Sonier M, et al
    Dosimetric Impact of Using a Virtual Couch Shift for Online Correction of Setup Errors for Brain Patients on an Integrated High-Field Magnetic Resonance Imaging Linear Accelerator.
    Int J Radiat Oncol Biol Phys. 2017;98:699-708.
    PubMed     Abstract available


  240. SU TS, Liang P, Liang J, Lu HZ, et al
    Long-Term Survival Analysis of Stereotactic Ablative Radiotherapy Versus Liver Resection for Small Hepatocellular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2017;98:639-646.
    PubMed     Abstract available


  241. RIEBER J, Abbassi-Senger N, Adebahr S, Andratschke N, et al
    Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease.
    Int J Radiat Oncol Biol Phys. 2017;98:511-520.
    PubMed     Abstract available


  242. CORKUM MT
    Prostate Cancer With Isolated Bony Metastasis: Sternal Struggle.
    Int J Radiat Oncol Biol Phys. 2017;98:492-493.
    PubMed    


    June 2017
  243. CLARKE J, Neil E, Terziev R, Gutin P, et al
    Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
    Int J Radiat Oncol Biol Phys. 2017 Jun 30. pii: S0360-3016(17)33549.
    PubMed     Abstract available


  244. SHENG Y, Li T, Lee WR, Yin FF, et al
    Exploring the Margin Recipe for Online Adaptive Radiation Therapy for Intermediate-Risk Prostate Cancer: An Intrafractional Seminal Vesicles Motion Analysis.
    Int J Radiat Oncol Biol Phys. 2017;98:473-480.
    PubMed     Abstract available


  245. HELOU J, Thibault I, Poon I, Chiang A, et al
    Stereotactic Ablative Radiation Therapy for Pulmonary Metastases: Histology, Dose, and Indication Matter.
    Int J Radiat Oncol Biol Phys. 2017;98:419-427.
    PubMed     Abstract available


    May 2017
  246. RAHIMI A, Thomas K, Spangler A, Rao R, et al
    Preliminary Results of a Phase 1 Dose-Escalation Trial for Early-Stage Breast Cancer Using 5-Fraction Stereotactic Body Radiation Therapy for Partial-Breast Irradiation.
    Int J Radiat Oncol Biol Phys. 2017;98:196-205.
    PubMed     Abstract available


  247. FARRIS M, McTyre ER, Cramer CK, Hughes R, et al
    Brain Metastasis Velocity: A Novel Prognostic Metric Predictive of Overall Survival and Freedom From Whole-Brain Radiation Therapy After Distant Brain Failure Following Upfront Radiosurgery Alone.
    Int J Radiat Oncol Biol Phys. 2017;98:131-141.
    PubMed     Abstract available


  248. POLLOM EL, Fujimoto D, Wynne J, Seiger K, et al
    Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results.
    Int J Radiat Oncol Biol Phys. 2017;98:123-130.
    PubMed     Abstract available


  249. WANG CJ, Christie A, Lin MH, Jung M, et al
    Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.
    Int J Radiat Oncol Biol Phys. 2017;98:91-100.
    PubMed     Abstract available


  250. CHEN AM, Yoshizaki T, Velez MA, Mikaeilian AG, et al
    Tolerance of the Brachial Plexus to High-Dose Reirradiation.
    Int J Radiat Oncol Biol Phys. 2017;98:83-90.
    PubMed     Abstract available


  251. YAZICI G, Kiratli H, Ozyigit G, Sari SY, et al
    Stereotactic Radiosurgery and Fractionated Stereotactic Radiation Therapy for the Treatment of Uveal Melanoma.
    Int J Radiat Oncol Biol Phys. 2017;98:152-158.
    PubMed     Abstract available


  252. HRYCUSHKO BA, Chopra R, Sayre JW, Richardson JA, et al
    Local Hypothermia as a Radioprotector of the Rectal Wall During Prostate Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;98:75-82.
    PubMed     Abstract available


  253. RITTER TA, Matuszak M, Chetty IJ, Mayo CS, et al
    Application of Critical Volume-Dose Constraints for Stereotactic Body Radiation Therapy in NRG Radiation Therapy Trials.
    Int J Radiat Oncol Biol Phys. 2017;98:34-36.
    PubMed    


  254. COOPER JS
    Radiation Therapy Followed by Ipilimumab Is Appropriate.
    Int J Radiat Oncol Biol Phys. 2017;98:13.
    PubMed    


    April 2017
  255. VARGO JA, Ward MC, Caudell JJ, Riaz N, et al
    A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Apr 24. pii: S0360-3016(17)30821.
    PubMed     Abstract available


  256. VELEC M, Haddad CR, Craig T, Wang L, et al
    Predictors of Liver Toxicity Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2017;97:939-946.
    PubMed     Abstract available


  257. MANNINA EM, Cardenes HR, Lasley FD, Goodman B, et al
    Role of Stereotactic Body Radiation Therapy Before Orthotopic Liver Transplantation: Retrospective Evaluation of Pathologic Response and Outcomes.
    Int J Radiat Oncol Biol Phys. 2017;97:931-938.
    PubMed     Abstract available


  258. POLLOCK BE, Link MJ, Stafford SL, Parney IF, et al
    The Risk of Radiation-Induced Tumors or Malignant Transformation After Single-Fraction Intracranial Radiosurgery: Results Based on a 25-Year Experience.
    Int J Radiat Oncol Biol Phys. 2017;97:919-923.
    PubMed     Abstract available


  259. MCCOWAN PM, Asuni G, Van Uytven E, VanBeek T, et al
    Clinical Implementation of a Model-Based In Vivo Dose Verification System for Stereotactic Body Radiation Therapy-Volumetric Modulated Arc Therapy Treatments Using the Electronic Portal Imaging Device.
    Int J Radiat Oncol Biol Phys. 2017;97:1077-1084.
    PubMed     Abstract available


    March 2017
  260. CHAN M, Grehn M, Cremers F, Siebert FA, et al
    Dosimetric Implications of Residual Tracking Errors During Robotic SBRT of Liver Metastases.
    Int J Radiat Oncol Biol Phys. 2017;97:839-848.
    PubMed     Abstract available


  261. VERMA V, Shostrom VK, Zhen W, Zhang M, et al
    Influence of Fractionation Scheme and Tumor Location on Toxicities After Stereotactic Body Radiation Therapy for Large (>/=5 cm) Non-Small Cell Lung Cancer: A Multi-institutional Analysis.
    Int J Radiat Oncol Biol Phys. 2017;97:778-785.
    PubMed     Abstract available


  262. GUCKENBERGER M
    SBRT in eight fractions.
    Int J Radiat Oncol Biol Phys. 2017;97:653.
    PubMed    


  263. ZENG J, Lo SS
    SBRT in five fractions.
    Int J Radiat Oncol Biol Phys. 2017;97:652-653.
    PubMed    


  264. PALMA DA
    An Ultracentral Lung Tumor.
    Int J Radiat Oncol Biol Phys. 2017;97:651.
    PubMed    


  265. SHAVERDIAN N, Verruttipong D, Wang PC, Kishan AU, et al
    Exploring Value From the Patient's Perspective Between Modern Radiation Therapy Modalities for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2017;97:516-525.
    PubMed     Abstract available


  266. MELOTEK JM, Chmura SJ
    Oligometastasis-Directed Ablative Therapy: A Clinical Trial Question.
    Int J Radiat Oncol Biol Phys. 2017;97:448.
    PubMed    


  267. FANG P
    Internal Mammary Misfortune.
    Int J Radiat Oncol Biol Phys. 2017;97:447.
    PubMed    


    February 2017
  268. PETRELLI F, Comito T, Ghidini A, Torri V, et al
    Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer: A Systematic Review and Pooled Analysis of 19 Trials.
    Int J Radiat Oncol Biol Phys. 2017;97:313-322.
    PubMed     Abstract available


  269. GOROVETS D, Ayala-Peacock D, Tybor DJ, Rava P, et al
    Multi-institutional Nomogram Predicting Survival Free From Salvage Whole Brain Radiation After Radiosurgery in Patients With Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2017;97:246-253.
    PubMed     Abstract available


  270. BOYCE-FAPPIANO D, Elibe E, Schultz L, Ryu S, et al
    Analysis of the Factors Contributing to Vertebral Compression Fractures After Spine Stereotactic Radiosurgery.
    Int J Radiat Oncol Biol Phys. 2017;97:236-245.
    PubMed     Abstract available


    January 2017
  271. MEHRABIAN H, Desmond KL, Chavez S, Bailey C, et al
    Water Exchange Rate Constant as a Biomarker of Treatment Efficacy in Patients With Brain Metastases Undergoing Stereotactic Radiosurgery.
    Int J Radiat Oncol Biol Phys. 2017 Jan 10. pii: S0360-3016(17)30020.
    PubMed     Abstract available


  272. GIULIANI M, Hope A, Guckenberger M, Mantel F, et al
    Stereotactic Body Radiation Therapy in Octo- and Nonagenarians for the Treatment of Early-Stage Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Jan 9. pii: S0360-3016(17)30023.
    PubMed     Abstract available


  273. REDMOND KJ, Robertson S, Lo SS, Soltys SG, et al
    Consensus Contouring Guidelines for Postoperative Stereotactic Body Radiation Therapy for Metastatic Solid Tumor Malignancies to the Spine.
    Int J Radiat Oncol Biol Phys. 2017;97:64-74.
    PubMed     Abstract available


  274. AL-HALLAQ HA, Chmura SJ, Salama JK, Lowenstein JR, et al
    Benchmark Credentialing Results for NRG-BR001: The First National Cancer Institute-Sponsored Trial of Stereotactic Body Radiation Therapy for Multiple Metastases.
    Int J Radiat Oncol Biol Phys. 2017;97:155-163.
    PubMed     Abstract available


  275. THIBAULT I, Whyne CM, Zhou S, Campbell M, et al
    Volume of Lytic Vertebral Body Metastatic Disease Quantified Using Computed Tomography-Based Image Segmentation Predicts Fracture Risk After Spine Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;97:75-81.
    PubMed     Abstract available


  276. LEEMAN JE, Rimner A, Montecalvo J, Hsu M, et al
    Histologic Subtype in Core Lung Biopsies of Early-Stage Lung Adenocarcinoma is a Prognostic Factor for Treatment Response and Failure Patterns After Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;97:138-145.
    PubMed     Abstract available


  277. SCHULER E, Trovati S, King G, Lartey F, et al
    Experimental Platform for Ultra-high Dose Rate FLASH Irradiation of Small Animals Using a Clinical Linear Accelerator.
    Int J Radiat Oncol Biol Phys. 2017;97:195-203.
    PubMed     Abstract available


  278. POSNER M, Gupta V
    Robotic Surgery plus Chemo-Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;97:4-5.
    PubMed    


    December 2016
  279. BROOKS ED, Sun B, Zhao L, Komaki R, et al
    Stereotactic Ablative Radiation Therapy is Highly Safe and Effective for Elderly Patients With Early-stage Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Dec 21. pii: S0360-3016(16)33596.
    PubMed     Abstract available


  280. STAHL JM, Ross R, Harder EM, Mancini BR, et al
    The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96:1011-1020.
    PubMed     Abstract available


  281. VIDETIC GM
    Early-Stage Lung Cancer, Surgery, and Stereotactic Body Radiation Therapy: Quality of Life.
    Int J Radiat Oncol Biol Phys. 2016;96:927-930.
    PubMed    


    November 2016
  282. VERMA V, Simone CB 2nd, Allen PK, Gajjar SR, et al
    Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Nov 2. pii: S0360-3016(16)33392.
    PubMed     Abstract available


  283. DU S, Lockamy V, Zhou L, Xue C, et al
    Stereotactic Body Radiation Therapy Delivery in a Genetically Engineered Mouse Model of Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96:529-37.
    PubMed     Abstract available


    October 2016
  284. MUI WH, Lam TC, Wong FC, Sze WK, et al
    Survival Analysis of Malignant Epidural Spinal Cord Compression After Palliative Radiation Therapy Using Tokuhashi Scoring System and the Impact of Systemic Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    


  285. LEE VH, Lam TW, Ng SC, Szeto MH, et al
    Effect of Titanium Hardware on Radiation Dosimetry in Postoperative Proton Versus Photon Spinal Stereotactic Body Radiation Therapy After Surgical Decompression for Spinal Cord Compression.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    


  286. SAADATMAND HJ, Wu CC, Lesser J, Isaacson SR, et al
    Improved Outcomes in Acoustic Neuroma Patients Receiving Stereotactic Radiosurgery from a Single Neurosurgeon at a High-Volume Institution.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    


  287. TAUBE S, Smith AW, Hirschfeld C, Nedialkova L, et al
    Clinical Outcomes of Large Brain Metastases Treated With Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    


  288. GESTAUT MM, Thawani N, Kim S, Gutti VR, et al
    Spine Stereotactic Ablative Body Radiation Therapy (SABR) With Volumetric Modulated Arc Therapy (VMAT) for Vertebral Metastases With and Without Metastatic Spinal Cord Compression (MSCC).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    


  289. PENNINGTON JD, Kishan AU, Chen AM
    Simulated Consult and Treatment of Malignant Epidural Spinal Cord Compression Improves Trainee Confidence and Knowledge Prior to Taking Radiation Oncology Call.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed    


    September 2016
  290. VERMA V, McMillan MT, Grover S, Simone CB 2nd, et al
    Stereotactic Body Radiation Therapy and the Influence of Chemotherapy on Overall Survival for Large (>/=5 Centimeter) Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Sep 29. pii: S0360-3016(16)33247.
    PubMed     Abstract available


  291. MILLER JA, Bennett EE, Xiao R, Kotecha R, et al
    Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis.
    Int J Radiat Oncol Biol Phys. 2016 Sep 1. pii: S0360-3016(16)33154.
    PubMed     Abstract available


    August 2016
  292. HEPEL JT, Leonard KL, Safran H, Ng T, et al
    Stereotactic Body Radiation Therapy Boost After Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Dose Escalation Study.
    Int J Radiat Oncol Biol Phys. 2016 Aug 31. pii: S0360-3016(16)33147.
    PubMed     Abstract available


  293. BI N, Shedden K, Zheng X, Kong FM, et al
    Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage I Non-Small Cell Lung Cancer: A Systemic Review and Pooled Analysis.
    Int J Radiat Oncol Biol Phys. 2016;95:1378-90.
    PubMed     Abstract available


    July 2016
  294. LING DC, Vargo JA, Ferris RL, Ohr J, et al
    Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2016;95:973-80.
    PubMed     Abstract available


  295. KOTECHA R, Djemil T, Tendulkar RD, Reddy CA, et al
    Dose-Escalated Stereotactic Body Radiation Therapy for Patients With Intermediate- and High-Risk Prostate Cancer: Initial Dosimetry Analysis and Patient Outcomes.
    Int J Radiat Oncol Biol Phys. 2016;95:960-4.
    PubMed     Abstract available


    June 2016
  296. ROSSI MM, Peulen HM, Belderbos JS, Sonke JJ, et al
    Intrafraction Motion in Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer: Intensity Modulated Radiation Therapy Versus Volumetric Modulated Arc Therapy.
    Int J Radiat Oncol Biol Phys. 2016;95:835-43.
    PubMed     Abstract available


  297. MULDERMANS JL, Romak LB, Kwon ED, Park SS, et al
    Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;95:696-702.
    PubMed     Abstract available


    April 2016
  298. PEULEN H, Mantel F, Guckenberger M, Belderbos J, et al
    Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Apr 12. pii: S0360-3016(16)30106.
    PubMed     Abstract available


    March 2016
  299. MINNITI G, Scaringi C, Paolini S, Lanzetta G, et al
    Single-Fraction Versus Multifraction (3 x 9 Gy) Stereotactic Radiosurgery for Large (>2 cm) Brain Metastases: A Comparative Analysis of Local Control and Risk of Radiation-Induced Brain Necrosis.
    Int J Radiat Oncol Biol Phys. 2016 Mar 19. pii: S0360-3016(16)00325.
    PubMed     Abstract available


    February 2016
  300. SONG C, Hong BJ, Bok S, Lee CJ, et al
    Real-time Tumor Oxygenation Changes After Single High-dose Radiation Therapy in Orthotopic and Subcutaneous Lung Cancer in Mice: Clinical Implication for Stereotactic Ablative Radiation Therapy Schedule Optimization.
    Int J Radiat Oncol Biol Phys. 2016 Feb 13. pii: S0360-3016(16)00138.
    PubMed     Abstract available


  301. SHEN CJ, Kummerlowe MN, Redmond KJ, Rigamonti D, et al
    Stereotactic Radiosurgery: Treatment of Brain Metastasis Without Interruption of Systemic Therapy.
    Int J Radiat Oncol Biol Phys. 2016 Feb 9. pii: S0360-3016(16)00107.
    PubMed     Abstract available


  302. MAGNUSON WJ, Yeung JT, Guillod PD, Gettinger SN, et al
    Impact of Deferring Radiation Therapy in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Develop Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2016 Feb 2. pii: S0360-3016(16)00058.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neurosurgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: